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Open access under CC BYDifferentiation-therapy is an important approach in the treatment of cancer, as in the case of erythroid
induction in chronic myelogenous leukemia. Moreover, an important therapeutic strategy for treating
beta-thalassemia and sickle-cell anemia could be the use of drugs able to induce erythroid differentiation
and fetal hemoglobin (HbF) accumulation: in fact, the increased production of this type of hemoglobin
can reduce the clinical symptoms and the frequency of transfusions. An important class of erythroid dif-
ferentiating compounds and HbF inducers is composed by DNA-binding chemotherapeutics: however,
they are not used in most instances considering their possible devastating side effects. In this contest,
we approached the study of erythrodifferentiating properties of furocoumarins. In fact, upon UV-A irra-
diation, they are able to covalently bind DNA. Thus, the erythrodifferentiation activity of some linear and
angular furocoumarins was evaluated in the experimental K562 cellular model system. Quantitative real-
time reverse transcription polymerase-chain reaction assay was employed to evaluate the accumulation
of different globin mRNAs. The results demonstrated that both linear and angular furocoumarins are
strong inducers of erythroid differentiation of K562 cells. From a preliminary screening, we selected
the most active compounds and investigated the role of DNA photodamage in their erythroid inducing
activity and mechanism of action. Moreover, some cytoﬂuorimetric experiments were carried out to bet-
ter study cell cycle modiﬁcations and the mitochondrial involvement. A further development of the work
was carried out studying the erythroid differentiation of photolysis products of these molecules. 5,50-
Dimethylpsoralen photoproducts induced an important increase in c-globin gene transcription in K562
cells.
 2013 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Furocoumarins are well known natural or synthetic compounds,
which derive from a linear (psoralens) or angular (angelicins) con-
densation of a coumarin with a furan ring. Some of them are em-
ployed in PUVA (Psoralen + UVA) therapy for the treatment of
autoimmune or hyper-proliferative skin diseases, including psoria-
sis and vitiligo. PUVA therapy efﬁcacy is due to a combination of
psoralen administration and UV-A irradiation. In fact, when acti-
vated by UV-A light, furocoumarins induce many biological effects,f Sciences of Drug, University
9 049 8275034; fax: +39 049
nd Biotechnology, University
ly. Tel.: +39 532 974443; fax:
A. Salvador), gam@unife.it
-NC-ND license.such as photocycloadditions to DNA, immune system modulation,
reactions with proteins, RNA and lipids [1]. Thanks to the develop-
ment of the photopheresis, the PUVA therapy has ampliﬁed its
application to some speciﬁc tumor forms such as cutaneous T-cell
lymphoma [2].
Although the ﬁrst furocoumarin was introduced in clinical prac-
tice as early as 1974 [3], these molecules still draw the attention of
the scientiﬁc community. In fact, many new potential therapeutic
applications for furocoumarins are found. For instance, some psor-
alen derivatives, such as 8-methoxypsoralen, showed anticonvul-
sant properties [4]; 4,6,40-trimethylangelicin demonstrated to be
potentially useful in the treatment of cystic ﬁbrosis thanks to its
anti-inﬂammatory activity and its potentiating action on the CFTR
membrane channel whose dysfunction causes that disease [5].
Moreover, furocoumarins were found to induce various processes
of differentiation. Psoralen is able to stimulate osteoblast differen-
tiation without irradiation as demonstrated by Tang et al. [6],
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erythroid differentiation in different cellular models [7–9]. This
latter property can be useful for the treatment of hematologic dis-
eases, such as b-thalassemia: at present, an important therapeutic
strategy is the administration of fetal hemoglobin (Hb) inducers to
reduce clinical symptoms and blood transfusion requirement [10].
The aim of our study was to evaluate the activity of six linear
and ﬁve angular furocoumarins on the induction of erythroid dif-
ferentiation expression of globin genes in the human leukemia cell
line K562. These molecules were not fully checked for their poten-
tial erythro-differentiation so far. The K562 cell line, isolated from
a patient with chronic myelogenous leukemia in blast crisis, is of-
ten used as in vitro experimental system for the ﬁrst screening of
new fetal Hb inducers [11]. The K562 cell line presents a low
amount of Hb-synthesizing cells under standard cell-growth con-
ditions. After the treatment with suitable inducing compounds,
massive erythroid induction occurs, with a clear increase in the
expression of human a and c globin genes and a cytoplasmic accu-
mulation of Hb Portland (f2c2) and Hb Gower 1 (f2e2) [10,12,13].
We then focused our attention on the most active compounds in
order to obtain preliminary data about their mechanism of action
and about the mode of cellular death induced by them.
A second part of our study was related to the well established
observation that after UV-A irradiation, psoralens undergo photol-
ysis with the formation of new species in solution, the so called
photooxidation photoproducts (POPs). POPs also present some bio-
logical activity: in fact, some papers showed their antileukemic
and immunosuppressive effects, which led us to hypothesize their
possible biological contribution in PUVA therapy [14,15]. Recently,
we also isolated and reported the erythroid differentiation induc-
tion by a speciﬁc 5-methoxypsoralen photoproduct [16].
Thus, the effect of POPs was also evaluated on the expression of
embryo-fetal globin genes in K562 cells by quantititative real-time
reverse transcription polymerase-chain reaction assay (RT-qPCR).2. Materials and methods
2.1. Chemicals and cellular buffers and media
Psoralens and angelicins belong to the collection of the Sciences
of Drug Department in Padova University [17–19]. If not speciﬁed
elsewhere, all chemicals, biological buffers and cellular media were
purchased from Sigma–Aldrich.
2.2. Irradiation procedure
Two HPW 125 Philips lamps, mainly emitting at 365 nm, were
used for irradiation experiments. The spectral irradiance of the
source was 4.0 mW cm2 as measured at the sample level by a
Cole-Parmer Instrument Company radiometer (Niles, IL, USA)
equipped with a 365-CX sensor.
2.3. Cell culture
The human leukemia K562 cells were cultured in a humidiﬁed
atmosphere of 5% CO2/air in RPMI 1640 medium, supplemented
with 10% fetal bovine serum (FBS; Invitrogen), 100 units/mL peni-
cillin and 100 mg/mL streptomycin.
2.3.1. Phototoxicity and benzidine test
Suspensions of 30,000 K562 cells/mL in complete medium were
seeded in individual wells of a 24-well tissue culture microtiter
plate. The plates were incubated at 37 C for 24 h prior to the
experiments. Stock solutions of furocoumarin derivatives were
prepared in methanol and then diluted with Hank’s balanced saltsolution (HBSS pH 7.2; the concentration of methanol was always
lower than 0.5%) for irradiation experiments. After medium re-
moval, 1 mL of the drug solution was added to each well, incubated
at 37 C for 30 min and then irradiated (1 and 2 J/cm2, which cor-
respond to 4 and 8 min of irradiation at 0.25 J/cm2). After irradia-
tion, the solution was replaced with complete medium and the
plates were incubated for 5–7 days. The medium was never chan-
ged during this period. Erythroid differentiation was determined
by counting blue benzidine-positive cells after suspending the cells
in a solution containing 0.2% benzidine in 10% H2O2 and 0.5 M
glacial acetic acid [7]. Cell phototoxicity was assessed by the MTT
[(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)]
test 5 days after irradiation [20]. The irreversibility of erythroid dif-
ferentiation was also assessed: 6 days after irradiation, 10,000 cells
were plated in a new plate with fresh medium and after further
4 days, they were counted after benzidine-staining as elsewhere
described [21].
2.3.2. Cell cycle analysis
1  106 K562 cells were incubated for 24 h and then irradiated
(1 J/cm2) in HBSS with or without the test compounds. After 24 h
from irradiation, cells were ﬁxed with ice-cooled ethanol (70% v/
v), treated overnight with RNAse A (0.1 mg/mL) in phosphate sal-
ine buffer and ﬁnally stained with propidium iodide (PI, 0.1 mg/
mL). Samples were analyzed on a BD FACS Calibur ﬂow cytometer
collecting 10,000 events. Results of cell-cycle analysis were exam-
ined using WinMDI 2.9 (Windows Multiple Document Interface for
Flow Cytometry) [20].
2.3.3. Mitochondrial dysfunction
K562 cells (300,000 cells/mL) were seeded in 24-well micro-
plate and incubated for 24 h prior irradiation. After medium re-
moval, 1 mL of the drug solution was added to each well,
incubated at 37 C for 30 min and then irradiated (1 J/cm2). After
irradiation, the solution was replaced with complete medium
and the plates were incubated for 24 h. Cells were collected by cen-
trifugation and re-suspended in 1 lM JC-1 (5,50,6,60-tetrachloro-
1,10,3,30-tetraethylbenzimidazol-carbocyanine) solution in HBSS
or in 100 nM NAO (10-N-nonyl acridine orange) solution in RPMI
medium. The cytoﬂuorimetric analysis (BD FACS Calibur ﬂow
cytometer) was performed collecting green (FL1) and orange
(FL2) ﬂuorescence for JC-1 staining and only the green one (FL1)
for NAO staining in at least 10,000 events for each sample [22,23].
2.4. Preparation of photoproducts
Solutions of derivatives in methanol were irradiated in a quartz
cuvette with different UV-A doses (0, 8, 16 and 32 J/cm2). After the
irradiation, the solution was lyophilized, suspended in a known
volume of methanol and stored at 20 C. Concentrations of un-
known photoproduct mixtures in this paper were expressed as if
the initial psoralen was not photodegraded.
2.5. mRNA measurements
RNA was isolated from K562 cells and measured by reverse
transcription quantitative real-time polymerase chain reaction
(RT-qPCR) as described [24] using gene-speciﬁc double ﬂuores-
cence labeled probes in an ABI Prism 7700 Sequence Detection Sys-
tem version 1.7.3 (Applied Biosystems). The following primer and
probe sequences were used: a-globin forward primer, 50-CAC
GCG CAC AAG CTT CG-30; a-globin reverse primer, 50-AGG GTC
ACC AGC AGG CAG T-30; a-globin probe, 50-FAM-TGG ACC CGG
TCA ACT TCA AGC TCC T-TAMRA-30; c-globin forward primer,
50-TGG CAA GAA GGT GCT GAC TTC-30; c-globin reverse primer,
50-TCA CTC AGC TGG GCA AAG G-30; c-globin probe, 50-FAM-TGG
Fig. 1. Furocoumarin structures.
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tive RT-PCR for f-globin mRNA and e-globin mRNA were from
Applied Biosystems (f-globin mRNA: Hs00923579_m1; e-globin
mRNA: Hs00362216_m1). The ﬂuorescent reporter and the
quencher were 6-carboxyﬂuorescein (FAM) and 6-carboxy-N,N,
N0,N0-tetramethylrhodamine (TAMRA), respectively. For real-time
PCR, the reference gene was 18S; this probe was ﬂuorescent-
labeled with VIC (Applied Biosystems) [24,25].
2.6. Statistical analysis
Unless indicated otherwise, results are presented as mean ±
SEM. The differences between different treatments were analyzed
using the two-sided Student’s t test; p values lower than 0.05 were
considered signiﬁcant ( = p < 0.05).1 For interpretation of color in Fig. 2, the reader is referred to the web version of
this article.3. Results
3.1. Furocoumarins induce erythroid differentiation and phototoxicity
The erythroid differentiation of K562 cells was investigated
after the treatment with six psoralens and ﬁve angelicins, whose
structures are described in Fig. 1. K652 cells were irradiated with
two UV-A doses (1 and 2 J/cm2) and then erythroid differentiation
was measured by benzidine test after 5, 6 and 7 days from irradi-
ation. At the same time, cellular viability was evaluated by MTT,
obtaining evidences suggesting antiproliferative effects and photo-
toxicity. Different concentrations of compounds were employed
because of their different phototoxic effects; accordingly, concen-
trations were chosen to maximize the erythroid effect without
extensive reduction of cell viability. Moreover, considering the fact
that some angelicins were powerful c-globin inducers without
irradiation [26], the same tests were performed with higher con-
centration of furocumarins in the absence of irradiation. With the
exception of 4,6,40-trimethylangelicin (4,6,40-TMA) [26], without
irradiation all furocoumarins, when administered at 50 lM,showed a very low capability of causing an increase of benzidine
positive cells (lower than 10%) with respect to control (data not
shown). On the contrary, after irradiation all tested molecules were
able to induce a clear increase of benzidine positive cells, as dis-
played in Table 1. Table 1 reports the percentages of benzidine po-
sitive cells and cellular viability after 6 days after irradiation at the
highest concentration for each compound. In general, psoralens in-
duced a higher proportion of erythroid differentiating cells (38.4–
78.1%) in comparison to angelicins (24.3–58.7%), and these data
conﬁrmed the ones obtained with other furocoumarins [7]. Fur-
thermore, the induction of erythroid differentiation was dependent
on the UV-A dose with the exception of some cases in which the
antiproliferative effect was a major effect (see for example 5,50-
dimethylpsoralen or 4,6,40-TMA or 4,40,50-trimethylangelicin). In
the panel A of Fig. 2, the concentration-dependent increase of the
ratio of benzidine positive cells was illustrated for some com-
pounds as examples. Moreover, the panel B of Fig. 2 shows repre-
sentative pictures of treated cells after benzidine staining: cells
irradiated in the presence of 40,50-dimethylpsoralen (40,50-DMP)
clearly were blue-colored1 and became larger with respect to con-
trol (this effect is not unusual within already reported inducers of
erythroid differentiation, such as cytosine arabinoside [10]). Fur-
ther experiments were carried out to determine whether the in-
duced erythroid differentiation was reversible. To this aim,
6 days after irradiation (1 J/cm2), K562 cells were incubated for
additional 4 days with fresh medium, and the benzidine test was
performed at this point. After 10 days, the percentage of erythroid
differentiation did not present any signiﬁcant variation in compar-
ison to the ones of the sixth day, with the exception of 5,50-DMP,
which exhibited a signiﬁcant increase in the proportion of benzi-
dine-positive cells (from 50.6 ± 5.0 to 66.8 ± 2.0). Considering the
fact that in erythroid-induced K562 cells the growth efﬁciency is
lower (see Tables 1 and 2), these evidences support the concept
Table 1
Differentiation and cellular viability after 6 days from irradiation with furocoumarins.
% Benzidine positive cellsa % Cellular viabilityb
1 J/cm2 2 J/cm2 1 J/cm2 2 J/cm2
Control 1.5 ± 0.5 1.8 ± 0.4 98.0 ± 2.5 97.5 ± 1.4
Psoralens
50-MP 1 lM 58.7 ± 1.9 78.1 ± 5.1 65.5 ± 2.5 45.7 ± 3.6
40 ,50-DMP 5 lM 60.7 ± 1.1 72.2 ± 5.0 73.7 ± 3.7 54.0 ± 2.5
5,50-DMP 1 lM 50.6 ± 5.0 44.5 ± 2.7 48.8 ± 6.7 19.5 ± 2.6
8,40-DMP 1 lM 38.4 ± 1.9 42.7 ± 1.7 60.9 ± 3.7 35.8 ± 3.9
3,4,8,40-TMP 1 lM 43.5 ± 7.1 38.7 ± 1.7 39.4 ± 5.7 22.5 ± 1.9
50-Br-4,40-DMP 1 lM 40.2 ± 4.3 46.7 ± 4.5 88.7 ± 11.2 42.6 ± 3.7
Angelicins
50-MA 5 lM 24.3 ± 3.2 28.9 ± 4.8 97.7 ± 3.2 99.9 ± 4.5
3,4,40-TMA 1 lM 30.2 ± 2.2 39.4 ± 2.0 102.2 ± 11.2 57.8 ± 5.4
4,6,40-TMA 0.5 lM 58.7 ± 4.0 40.7 ± 4.3 60.9 ± 4.6 15.9 ± 3.4
4,40 ,50-TMA 5 lM 47.8 ± 6.9 18.9 ± 2.5 31.1 ± 2.5 9.2 ± 2.2
6,40 ,50-TMA 1 lM 33.5 ± 4.0 42.4 ± 1.9 74.3 ± 8.2 44.4 ± 5.5
a Data are expressed as media ± S.E.M. of at least four different independent experiments.
b Data are obtained by MTT and are expressed as media ± S.E.M. of at least four different independent experiments.
Fig. 2. Erythroid differentiation photoinduced by furocoumarins. Panel A. Percentage of benzidine positive cells after 6 days from irradiation (1 J/cm2) of K562 cells in the
presence of the indicated concentrations of 50-MP, 40 ,50-DMP, 5,50-DMP and 4,6,40-TMA. Results are expressed as media ± S.E.M. of at least 4 different experiments. Panel B.
Representative pictures (20) of benzidine stained K562 cells 6 days after irradiation (1 J/cm2) by light microscope: control in the left picture, 5 lM 40 ,50-DMP in the right one.
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the absence of irradiated compounds in the medium (this ‘‘com-
mitment-like’’ effect is present in several inducers of K562 cell dif-
ferentiation). In any case, the data suggest that the induced
differentiation observed at day 6 is irreversible.
Since 50-methylpsoralen (50-MP), 40,50-DMP and 5,50-dimethylp-
soralen (5,50-DMP) for psoralens and 4,6,40-TMA for angelicins
were the most active compounds, further experimental activity
was carried out with these molecules. Moreover, the lower UV-A
(1 J/cm2) dose was chosen to minimize the phototoxic effect.3.2. Erythroid differentiation is linked to DNA damage
The mechanism by which erythroid differentiation induced by
furocoumarin takes place is still unknown. However, the DNA
photobinding is considered the main effect for the photoantiprolif-
erative activity of the PUVA therapy. Thus, some preliminary
experiments were carried out to verify whether furocoumarin
DNA photodamage could be involved also in the erythroid differen-
tiation process. K562 cells were irradiated in the presence of the
tested compounds and of the inhibitors of some phosphoinositide
kinase-related kinases, such as DNA-dependent protein kinase
(DNA-PK), ataxia telangiectasia mutated (ATM) and the ataxia-
and Rad3-related protein (ATR), which can be activated after differ-
ent kinds of DNA damage [27]. In particular, wortmannin was usedFig. 3. Involvement of DNA photodamage in erythroid differentiation by
furocoumarins. Percentage of benzidine positive cells after 6 days from irradiation
from irradiation (1 J/cm2) of K562 cells in the presence of 1 lM 50-MP, 5 lM 40 ,50-
DMP, 1 lM 5,50-DMP and 0.5 lM 4,6,40-TMA. The irradiation was carried out in the
presence or absence of 10 lM Wortmannin (upper panel) or of 1 mM caffeine
(lower panel). Results are expressed as media ± S.E.M. of at least four different
experiments. C = irradiated control.as inhibitor of the catalytic subunit of the PI3-kinase family of en-
zymes [28], and caffeine as inhibitor of ATM and ATR but not of
DNA-PK [29]. Cell viability was not affected by the presence of
these two inhibitors (data not shown). As it can be observed in
Fig. 3, the amount of benzidine positive cells was signiﬁcantly re-
duced, even if not completely abolished, for all tested compounds,
when the irradiation was carried out in the presence of those
inhibitors. Thus, the processes activated by DNA damage could
be involved, at least in part, in the erythroid differentiation
process.
3.3. Furocoumarin induce increased expression of globin genes
The effects of furocoumarins on the expression of human globin
genes were determined by RT-qPCR analysis using probes amplify-
ing the a-like a-globin and f-globin and the b-like e-globin and
c-globin mRNA sequences. Effects on production of b-globin mRNA
were not analyzed, since it is well known that K562 cells do not
efﬁciently transcribe the b-globin genes [10,30]. In Fig. 4, globin
mRNA expression for 40,50-DMP and 4,6,60-TMA is presented; these
two molecules were selected as an example for linear (40,50-DMP)
and angular (4,6,40-TMA) most active furocoumarins in inducing
erythroid differentiation (Table 1). The results were reproducible
and demonstrate that: (a) when K562 cells were irradiated
(1 J/cm2) in the absence of the compounds, only minor effects were
observed on accumulation of globin mRNAs; (b) the induction of
globin gene expression is not enhanced by low concentrations of
furocoumarins without irradiation; however, (c) when irradiationFig. 4. Increase in a-, c-, e- and f-globin mRNA content in K562 cells irradiated
(1 J/cm2) or incubated (dark) in the presence of 40 ,50-DMP (upper panel) and 4,6,40-
TMA (lower panel) at the indicated concentrations. Expression of globin genes was
assayed by quantitative reverse transcriptase polymerase-chain reaction (qRT-PCR)
after 6 days from the irradiation/incubation. CI = irradiated control.
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two furocoumarins, a dose-dependent increase in globin mRNA
expression was observed. The level of induction was found to be
dose-dependent, all the analyzed globin mRNAs were clearly in-
duced, the level of induction was dramatic for a-globin, f-globin
and c-globin mRNA sequences, but clearly evident also for e-globinFig. 5. Representative histograms of cell cycles after irradiation of K562 cells in the
presence of furocoumarins. Cells were irradiated (1 J/cm2) at the indicated
concentrations of 50-MP, 40 ,50-DMP, 5,50-DMP and 4,6,40-TMA and after 24 h of
incubation were labeled with propidium iodide and analyzed.mRNA. When the experiment was repeated (n = 3) using the high-
est furocoumarin concentration reproducible results were ob-
served, and if the results were compared to reference K562 cells
treated with a control HbF inducer, this induction level was higher
than the most effective K562 erythroid inducer available, 1-octyl-
thymine [30]. In fact the induction of f-globin mRNA was
48.5-fold ± 8.5 for 40,50-DMP, 64.6-fold ± 8.2 for 4,6,40-TMA and
37-fold ± 6.8 for 1-octylthymine (data not shown and Ref. [30]).
3.4. Furocoumarins induce a block in G2-M phase and cause cell death
by apoptosis
To further study the effects of furocoumarins on cell prolifera-
tion, a cell cycle analysis was carried out after 24 h from the irra-
diation of K562 in the presence of two different concentrations of
the compounds (Fig. 5). This test is based on the fact that each cell
cycle phase presents a different DNA content, which was quanti-
ﬁed by propidium iodide (PI) staining. The irradiation of K562 with
all tested furocoumarins caused a reduction of G1 phase together
with a clear accumulation of cells in G2-M phase (see Table 2). This
G2-M block was consistent with the effect of other furocoumarins
in the same cell line [7]. Moreover, indications of cell death by
apoptosis were detected as DNA fragments in sub-G1 phase.
3.5. Furocoumarins induce cell death and erythroid differentiation
with the involvement of mitochondria
As furocoumarins are known to photoinduce apoptosis with the
involvement of mitochondria, the role of these organelles was eval-
uated with two different ﬂow cytometry tests [31]. Impairment in
mitochondrial function is an early event in the executive phase of
programmed cell death in different cell types and appears as the
consequence of a preliminary reduction of the mitochondrial
transmembrane potential (DWM). The lipophilic cation JC-1 was
used to monitor the changes in DWM induced by the tested com-
pounds in combination with UV-A irradiation. Another conse-
quence of mitochondrial dysfunction is the production of reactive
oxygen species which oxidized the mitochondrial phospholipid
cardiolipin (CL). CL oxidation was monitored by staining irradiated
cells with N-nonyl acridine orange (NAO) as described in Section
2.3.3.
A concentration-dependent increase of the percentage of cells
with a collapsed DWM can be observed after JC-1 staining (Fig. 6,
upper panel): this may be an indication of the opening of the mito-
chondrial mega-channels also called the permeability transition
pores (PTPs).
NAO interacts stoichiometrically with intact non-oxidized car-
diolipin. In good agreement with the collapsed mitochondrial
potentials, treated cells showed an increase in the oxidized CL
(Fig. 6, lower panel).Table 2
Percentage of K562 cells in each cell cycle phase after 24 h from irradiation (1 J/cm2)
in the presence of the indicated concentration of furocoumarins.
G1a S G2-M subG1
Control 43.9 25.1 23.0 8.0
50-MP 1b 14.0 12.0 63.2 10.8
50-MP 0.5 22.8 14.6 50.5 12.0
40 ,50-DMP 5 7.3 15.1 59.5 18.4
40 ,50-DMP 2.5 8.9 9.3 70.8 11.0
5,50-DMP 1 9.2 24.0 35.2 31.6
5,50-DMP 0.5 7.1 14.3 63.6 15.0
4,6,40-TMA 0.5 9.4 12.6 64.0 14.0
4,6,4’-TMA 0.25 17.2 17.6 44.2 21.0
a Percentage of cells.
b lM.
Fig. 6. Mitochondrial dysfunction photoinduced by furocoumarins. Percentage of
cells with loss of mitochondrial membrane potential (upper panel) and with
oxidized cardiolipin (lower panel) after 24 h from the irradiation (1 J/cm2) in the
presence of the indicated concentrations of 50-MP, 40 ,50-DMP, 5,50-DMP and 4,6,40-
TMA. C = irradiated control. Data are expressed as mean ± S.E.M. of three indepen-
dent experiments.
Fig. 7. Involvement of mitochondrial pathway in erythroid differentiation by
furocoumarins. Percentage of benzidine positive cells after 6 days from irradiation
from irradiation (1 J/cm2) of K562 cells in the presence of 1 lM 50-MP, 5 lM 40 ,50-
DMP, 1 lM 5,50-DMP and 0.5 lM 4,6,40-TMA. The irradiation was carried out in the
presence or absence of 50 lM z-VAD.fmk. Results are expressed as media ± S.E.M. of
at least three different experiments. C = irradiated control.
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throid differentiation and mitochondrial impairment. In particular,
the involvement of the mitochondrial pathway via activation of
caspase-3 and caspase-9 was evaluated; to this aim, K562 cells
were irradiated in the presence of the pancaspase inhibitor z-
VAD.fmk and then benzidine test was performed. As shown in
Fig. 7, z-VAD.fmk suppressed erythroid differentiation induced by
all furocumarins.
3.6. 5,50-DMP photoproducts induce erythroid differentiation
We also studied the possible erythroid differentiation activity of
irradiated mixtures of some tested furocoumarins. These com-
pounds were 50-MP, 40,50-DMP and 5,50-DMP and were chosen on
the basis of their higher sensitivity to UV-A photodegradation (fol-
lowed by UV–vis spectroscopy- data not shown).
After their irradiation in methanol solution with different UV-A
doses (0, 8, 16 and 32 J/cm2), psoralens were concentrated by sol-
vent evaporation and then resuspended in methanol. The erythroid
differentiation of photoproducts was investigated by benzidine
test incubating K562 with psoralen irradiated mixtures at two dif-
ferent concentrations (50 and 200 lM) for 5–7 days. Cell growth
was also evaluated using the MTT assay after 6 days of treatment
(Table 3). After 6 days of incubation, cells treated with 50 lM
pre-irradiated mixtures did not show a clear increase of benzidine
positive cells (Fig. 8, upper panel) nor a decrease in cellular viabil-
ity in comparison to control (Table 3); on the contrary, using the
higher concentration, an induction of erythroid differentiation
(26–36% benzidine positive cells) (Fig. 8, lower panel) together
with a reduction of cellular viability was observed only with 5,50-
DMP (Table 3); the other POP mixtures exhibited low activity or
were inactive. The irreversibility of the erythroid differentiation
induction by 5,50-DMP photoproduct mixtures was also assessed.
The ﬁrst 6 days of treatment were sufﬁcient for K562 cells to differ-
entiate irreversibly since during additional 4 days of culturing in
the absence of the inducer of washed cells, the population of ben-
zidine-positive cells still increased (from 26.3 ± 3.1 to 44.3 ± 2.2 in
the case of 8 J and from 35.1 ± 2.0 to 40.5 ± 1.1 in the case of 16 J).
3.7. Furocoumarin photoproducts induce increased expression of
globin genes
RT-qPCR was also employed to quantify the expression of globin
mRNA following treatment of K562 cells with 5,50-DMP photo-
products. There is a clear positive relationship between UV-A doses
used to obtain the photoproducts and the extent of increased glo-
bin mRNAs in respect to control K562 cells (Fig. 9). As far as a pos-
sible differential activity of furocoumarin photoproducts on globin
gene expression is concerned, the data clearly indicate that accu-
mulation of both the a-like a-globin mRNA and f-globin mRNA
are strongly induced. On the contrary, among the b-like e-globin
and c-globin mRNAs, the c-globin mRNA is preferentially induced.
This conclusion is well in agreement with the data shown in Fig. 4Table 3
Percentage of cellular viability after incubation of 6 days of K562 with pre-irradiated
mixtures of 50-MP, 40 ,50-DMP and 5,50-DMP.
0 J/cm2 8 J/cm2 16 J/cm2 32 J/cm2
50-MP 50a 95.0 ± 4.5 93.0 ± 3.5 92.6 ± 4.8 89.8 ± 3.5
40 ,50-DMP 50 93.8 ± 2.3 94.5 ± 5.0 94.0 ± 4.6 92.9 ± 0.4
5,50-DMP 50 98.7 ± 5.8 94.8 ± 6.5 93.4 ± 3.5 94.3 ± 4.7
50-MP 200 88.9 ± 7.8 80.2 ± 3.6 84.5 ± 3.9 81.9 ± 4.9
40 ,50-DMP 200 86.0 ± 2.4 86.9 ± 6.2 96.8 ± 6.3 83.3 ± 2.8
5,50-DMP 200 99.8 ± 2.9 49.5 ± 2.3 22.4 ± 2.2 22.1 ± 1.9
a lM.
Fig. 8. Erythroid differentiation induced by furocoumarin photoproducts. Percent-
age of benzidine positive cells after 6 days of K562 cell incubation in the presence of
irradiated (0, 8, 16 and 32 J/cm2) mixtures of 50-MP, 40 ,50-DMP and 5,50-DMP: in the
upper panel, the concentration is 50 lM while in the lower panel it is 200 lM.
Results are expressed as media ± S.E.M. of at least three different experiments.
Fig. 9. Increase in a-, c-, e- and f-globin mRNA content in K562 cells incubated in
the presence of pre-irradiated mixtures of 5,50-DMP (0, 8 and 16 J/cm2) for 6 days.
The ﬁnal concentration was 200 lM. Expression of globin genes was assayed by
quantitative reverse transcriptase polymerase-chain reaction (qRT-PCR).
64 A. Salvador et al. / Journal of Photochemistry and Photobiology B: Biology 121 (2013) 57–66and concerning the effects of other furocoumarins on globin gene
expression in irradiated K562 cells.4. Discussion
In this study, we reported the antiproliferative effects and the
inducing activity on erythroid differentiation of some psoralen
and angelicin analogs in the human chronic myelogenous leukemia
K562 cell line. Some of us previously demonstrated that fur-
ocoumarins, in combination with UV-A, present the capability of
inducing erythroid differentiation like other DNA binders. Thus,
we decided to continue our research evaluating new derivatives,
some of them chosen on the basis of some considerations about
the structure–activity relationship. For instance, we focused our
attention on angelicin with trimethylation as this substitution
seemed to be successful for erythroid differentiation [26]. In fact,
trimethylangelicins resulted to induce higher percentages of benzi-
dine positive cells with respect to 50-MA (see Table 1). In the case of
psoralens, our aim was also to verify the role of the substitution of
furan ring, considering preliminary data demonstrating that
monomethylation on furan leads to a very active compound and
conﬁrmed the higher inducible power of methylpsoralens [7].
The dimethylation involving one or both furan positions led to very
interesting compounds, especially when the substitution on posi-
tion 8 is avoided. We also decided to evaluate new substitutions,
as tetramethylation or the introduction of an halogen, but they
do not seem to increase erythroid induction activity (see Table 1).
Interestingly, the most active compounds were able to induce a
clear and important increase of globin mRNA expression which was
much higher than that reported elsewhere for 5-methoxypsoralen
[8] (Fig. 4). It should be underlined that the level of induction
reached in these experimental conditions is even higher than that
exhibited by the most powerful inducer described [30].
Moreover, since the mechanism of erythroid differentiation
mediated by furocoumarins (in the presence or absence of UV-A
exposure) is not well understood, ﬁrst of all, some preliminary
analyses were performed to investigate the role of DNA damage.
Central to the DNA damage response are the ATM (ataxia-telangi-
ectasia mutated), ATR (ataxia-telangiectasia and Rad3-related) and
DNA-dependent protein kinases that modulate cell cycle progres-
sion, DNA repair, and sometimes, apoptosis. We observed a signif-
icant reduction of the levels of erythroid differentiation induced by
furocoumarins when irradiation was performed in the presence of
inhibitors of these kinases (see Fig. 3): this suggests that furocoum-
arin-mediated erythroid differentiation is at least partially medi-
ated by the DNA damage activated proteins. A role of DNA
damage can be also found by the analysis of cell cycle of irradiated
cells in the presence of furocoumarins since a clear block in G2-M
phase was observed (see Fig. 5 and Table 2). Furthermore, cell cycle
studies demonstrated that furocoumarins plus UV-A induced a cer-
tain degree of cell death (see Fig. 5) by apoptosis thanks to the
presence of a percentage of cells with a lower DNA content than
G1 phase. The role of mitochondria in cell death was also demon-
strated (Fig. 6). We also evaluated a possible role of mitochondrial
dysfunction and of apoptosis in erythroid differentiation and we
observed a clear suppression of the proportion of benzidine posi-
tive cells after mitochondrial pathway inhibition. These data indi-
cate that erythroid differentiation may be a consequence of a stress
response in which mitochondrial and DNA damage signaling are
involved.
In this report, we also aimed at studying a possible role of
photodegradation products in furocoumarin activity. The most
interesting photoproducts mixtures were those obtained with
5,50-DMP: in fact, the efﬁciency of these photoproducts in inducing
increase of globin mRNA content is dramatic and much higher than
those exhibited by other inducers of K562 erythroid differentia-
tion, such as cytosine arabinoside, butyric acid, mithramycin. This
supports the concept that this strategy might be of some interest in
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to be used in differentiation therapy.
The design and production of antiproliferative molecules target-
ing the K562 cell systemmight be of great interest for the develop-
ment of cocktails exhibiting applications in the treatment of chronic
myelogenous leukemia. For instance smenospongine [32], crambe-
scidin 800 [33] and doxorubicin derivatives [21] were reported as
molecules of possible interest for inhibiting of CML cell growth,
stimulating terminal differentiation along the erythroid program.
Some molecules, such as Pivanex (an HDAC inhibitor) [34] and a
morpholine derivative of doxorubicin [35], are synergistic with
the most common anti-CML agents, STI571 (Imatinib). In addition
to synergistic effects, molecules inducing differentiation might be
of great interest for treatment of Imatinib mesylate-resistant
human CML cell lines, as recently demonstrated for the phytoalexin
resveratrol [36].
As far as a possible differential activity of furocoumarin photo-
products on globin gene expression is concerned, the preferential
effects on c-globin mRNA might be also of interest for the develop-
ment of novel HbF inducers in thalassemia. At present, one of the
most promising novel approaches for the clinical management of
b-thalassaemia is the treatment of patients with chemical inducers
of endogenous HbF. On the basis of recent achievements obtained
in this research ﬁeld, several studies focusing on the mechanisms
regulating reactivation of HbF production in humans have been re-
ported. Relevant to these issues are studies showing that there is a
strong negative correlation between HbF levels and morbidities.
In conclusion, the results presented in this paper demonstrate
that the effects on erythroid differentiation of UV-A exposure of
K562 cells in the presence of linear and angular psoralens are part
of a general phenomenon. The differentiating activity of these com-
pounds in the presence of UV-A irradiation was associated with a
dramatic induction of accumulation of the a-like a-globin and
f-globin mRNA and the b-like e-globin and c-globin mRNA se-
quences. Of particular interest is our ﬁnding that erythroid induc-
tion and accumulation of c-globin mRNA can be also obtained with
psoralen plus UVA induced photolysis products. It will be of inter-
est to identify and characterize the active products involved.Acknowledgements
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